Entheon Biomedical Corp. reported earnings results for the third quarter and nine months ended August 31, 2022. For the third quarter, the company reported sales was CAD 0.000187 million compared to CAD 0.005899 million a year ago. Net income was CAD 0.458193 million compared to net loss of CAD 1.72 million a year ago. Basic earnings per share from continuing operations was CAD 0.01 compared to basic loss per share from continuing operations of CAD 0.03 a year ago. Diluted earnings per share from continuing operations was CAD 0.01 compared to diluted loss per share from continuing operations of CAD 0.03 a year ago.
For the nine months, sales was CAD 0.021072 million compared to CAD 0.007356 million a year ago. Net loss was CAD 2.68 million compared to CAD 7.02 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.13 a year ago.